Title : Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.

Pub. Date : 2011 Oct

PMID : 22015290






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin, a commonly used diabetes drug, lowers insulin in non-breast diabetic cancer patients, likely by reducing hepatic gluconeogenesis; it also appears to have potential insulin independent direct effects on tumor cells which are mediated by activation of AMPK with downstream inhibition of mTOR. Metformin mechanistic target of rapamycin kinase Homo sapiens